LITERATURE REVIEW
Preceding studies that recommended delaying tympanic membrane repair to 7 to 11 years of age lacked longterm follow-up. In 2007, Yung et al. published results from a full year after primary repair of central perforations due to chronic otitis media. 5 Previous studies may have missed late failures. Fifteen children aged 4 to 8 years were compared to 36 children aged 9 to 13 years, and success was defined as an "intact tympanic membrane, free from OME, atelectasis, ear discharge, and myringitis, and with no worsening of hearing." Success was achieved 63% of the time. They found no difference in outcome between the older and younger age groups for either the full definition of success or for any of the components of the definition.
The majority of publications evaluating pediatric age assessed repair with fascia grafts. After positive reports of perforation closure with cartilage grafts in adults, Friedman et al. compared type I cartilage tympanoplasty outcomes in a total of 119 patients in three age groups: age 4 to 7, 7 to 10, and 10 to 13 years. 2 They found no difference in graft take or audiological outcomes between the three groups. Their overall success ranked high at 95% at an average of 1.5 years after surgery. Their clinical algorithm is to perform tympanoplasty after 4 years of age. If the contralateral middle ear is abnormal, they will treat the nose, consider adenoidectomy, and delay tympanoplasty until age 7.
A prolonged delay of tympanic membrane repair may have negative long-term effects. An analysis by Knapik et al. of a cohort of 201 patients without dysmorphic syndromes who underwent tympanoplasty alone found no difference in anatomic outcomes between 0 to 11 years olds compared to 12 to 18 year olds. Anatomic failures were defined as ears with "perforations, middle ear cholesteatoma or tympanic membrane retractions higher than grade 1." 1 Although there was no difference in air-bone gaps between the two age strata, preoperative and postoperative bone conduction thresholds were significantly worse in the older cohort. Knapik et al postulated that this may be due to recurring infections in the setting of a chronic perforation that result in long-term irreversible inner ear damage.
Complications can also occur as a result of the procedure itself. Ribeiro et al. divided 79 tympanoplasties by patients aged < 10 years and > 10 years as the cutoff of expected Eustachian tube maturity. 3 The younger group included 13 patients who were 8 years old. Complications included chorda tympani injury, transient vertigo, wound, and external auditory canal infections. Anatomical success was defined as "an intact graft evaluated by microscopy and/or tympanometry without perforation, atelectasis or lateralization" and functional success as an air-bone gap < 20 dB (0.5-3 kHz). There was no difference in frequency of complications or anatomic or functional success between the two groups at an average of 25.6 months later.
Small sample sizes in single institution studies can limit the ability to detect a statistically significant difference between groups. Furthermore, we could not identify any prospective trials that addressed this clinical question. It is a challenge to design randomized control trials to evaluate this type of question, and blinding is not feasible. However, systematic reviews and meta-analysis of observational data can often offer equally robust and more generalizable data than a single prospective trial. There are some individual studies whose results support waiting to an older age to repair perforations in children. Another benefit of a systematic review with meta-analysis is that these opposing results can also be included in the analysis. In 2015, Hardman et al. published the most recent systematic review and meta-analysis investigating predictors of pediatric tympanoplasty success. 4 Individual studies that showed better outcomes with older age were included; however, there are relatively more studies included in this review that show no significant difference in outcomes based on age, and this accurately reflects the available published literature. Success was defined as perforation closure at 12 months and the mean success was 83.4%. Analysis by age was performed on five eligible studies, including 109 cases with an age range of 6 to 18 years, and found that age did not affect success of closure. In fact, linear regression showed a trend for higher closure rates in the younger patients, but this was not statistically significant (P 5 0.075). Additionally, six different studies that did not have the data for analysis by each age had data for perforation closure around a referent age of 11 years. These included a total of 645 cases and showed there was no significant difference between age groups of less than 11 years and greater than 11 years. Children with larger perforations (> 50%) or abnormal contralateral ear exam findings were significantly more likely to experience failure. Therefore, the review authors concluded that patient age is not an indication to delay tympanic membrane repair, but contralateral otitis media with effusion is a reason to delay until the signs and symptoms of chronic or recurrent effusions have resolved.
BEST PRACTICE
Based on the available data, age does not appear to directly mediate the perforation closure, hearing, or complication outcomes after tympanic membrane perforation repair in pediatric patients. Other factors are indicative of outcome, such as underlying Eustachian tube function based on the presence of recurrent otitis media and the aeration of the contralateral middle ear space. Therefore, there should not be a minimum age cutoff for considering tympanic membrane repair. It should be recommended as soon as clinically appropriate for each child because experiencing a similar surgical outcome at a younger age results in substantial time, cost, and quality of life savings for the child and family. Standardizing reports of anatomical and audiological success in future studies could help further elucidate the benefits of not delaying repair.
LEVEL OF EVIDENCE
Hardman: level 2a, systematic review of retrospective cohort studies. Knapik, Friedman, Riberio, and Yung: level 2b, individual retrospective cohort study.
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